Frontlight ResearchEarly access
Trial site
Midwest Center for Hematology Oncology
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia2 trials
- Colorectal cancer2 trials
- Multiple myeloma2 trials
- Childhood cancers1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Neuroendocrine tumours1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed3 trials
- Lead sponsor
- National Cancer Institute (NCI)8 trials
- ECOG-ACRIN Cancer Research Group1 trial
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Completed
Completed
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Site data: ClinicalTrials.govUpdated 14 Nov 2026